https://stock.noler.com/us/stock/biox https://stock.noler.com/us/stock/biox/13f-holdings https://stock.noler.com/us/stock/biox/accounting-profit https://stock.noler.com/us/stock/biox/acquisitions-through-business-combinations-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/biox/acquisitions-through-business-combinations-investment-property https://stock.noler.com/us/stock/biox/acquisitions-through-business-combinations-other-provisions https://stock.noler.com/us/stock/biox/activist-13d-13g https://stock.noler.com/us/stock/biox/additional-liabilities-contingent-liabilities-recognised-in-business-combination https://stock.noler.com/us/stock/biox/additional-provisions-other-provisions https://stock.noler.com/us/stock/biox/additions-other-than-through-business-combinations-biological-assets https://stock.noler.com/us/stock/biox/additions-other-than-through-business-combinations-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/biox/additions-other-than-through-business-combinations-property-plant-and-equipment https://stock.noler.com/us/stock/biox/adjusted-weighted-average-shares https://stock.noler.com/us/stock/biox/adjustments-for-amortisation-expense https://stock.noler.com/us/stock/biox/adjustments-for-decrease-increase-in-inventories https://stock.noler.com/us/stock/biox/adjustments-for-decrease-increase-in-other-operating-receivables https://stock.noler.com/us/stock/biox/adjustments-for-decrease-increase-in-trade-account-receivable https://stock.noler.com/us/stock/biox/adjustments-for-depreciation-expense https://stock.noler.com/us/stock/biox/adjustments-for-finance-costs https://stock.noler.com/us/stock/biox/adjustments-for-gain-loss-on-disposal-of-investments-in-subsidiaries-joint-ventures-and-associates https://stock.noler.com/us/stock/biox/adjustments-for-impairment-loss-reversal-of-impairment-loss-recognised-in-profit-or-loss https://stock.noler.com/us/stock/biox/adjustments-for-income-tax-expense https://stock.noler.com/us/stock/biox/adjustments-for-increase-decrease-in-trade-and-other-payables https://stock.noler.com/us/stock/biox/adjustments-for-losses-gains-on-disposal-of-noncurrent-assets https://stock.noler.com/us/stock/biox/adjustments-for-provisions https://stock.noler.com/us/stock/biox/adjustments-for-share-based-payments https://stock.noler.com/us/stock/biox/administrative-expense https://stock.noler.com/us/stock/biox/advertising-expense https://stock.noler.com/us/stock/biox/allowance-account-for-credit-losses-of-financial-assets https://stock.noler.com/us/stock/biox/amended-reports-10-k https://stock.noler.com/us/stock/biox/amortisation-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/biox/amounts-payable-related-party-transactions https://stock.noler.com/us/stock/biox/amounts-receivable-related-party-transactions https://stock.noler.com/us/stock/biox/analyst-ratings-buy https://stock.noler.com/us/stock/biox/analyst-ratings-hold https://stock.noler.com/us/stock/biox/analyst-ratings-no-rating https://stock.noler.com/us/stock/biox/analyst-ratings-sell https://stock.noler.com/us/stock/biox/applicable-tax-rate https://stock.noler.com/us/stock/biox/auditor https://stock.noler.com/us/stock/biox/average-exercise-price-of-share-options-outstanding-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/biox/basic-and-diluted-earnings-loss-per-share https://stock.noler.com/us/stock/biox/basic-earnings-loss-per-share https://stock.noler.com/us/stock/biox/basic-earnings-loss-per-share-from https://stock.noler.com/us/stock/biox/basic-earnings-loss-per-share-from-discontinued-operations https://stock.noler.com/us/stock/biox/biological-assets https://stock.noler.com/us/stock/biox/bonds-issued https://stock.noler.com/us/stock/biox/borrowings https://stock.noler.com/us/stock/biox/business https://stock.noler.com/us/stock/biox/buybacks https://stock.noler.com/us/stock/biox/cash https://stock.noler.com/us/stock/biox/cash-advances-and-loans-made-to-related-parties https://stock.noler.com/us/stock/biox/cash-and-bank-balances-at-central-banks https://stock.noler.com/us/stock/biox/cash-and-cash-equivalents https://stock.noler.com/us/stock/biox/cash-and-cash-equivalents-if-different-from-statement-of-financial-position https://stock.noler.com/us/stock/biox/cash-equivalents https://stock.noler.com/us/stock/biox/cash-flow-breakdown https://stock.noler.com/us/stock/biox/cash-flows-from-used-in-decrease-increase-in-shortterm-deposits-and-investments https://stock.noler.com/us/stock/biox/cash-flows-from-used-in-financing-activities https://stock.noler.com/us/stock/biox/cash-flows-from-used-in-financing-activities-discontinued-operations https://stock.noler.com/us/stock/biox/cash-flows-from-used-in-financing-activities-ifrs-full https://stock.noler.com/us/stock/biox/cash-flows-from-used-in-increase-decrease-in-current-borrowings https://stock.noler.com/us/stock/biox/cash-flows-from-used-in-investing-activities https://stock.noler.com/us/stock/biox/cash-flows-from-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/biox/cash-flows-from-used-in-investing-activities-ifrs-full https://stock.noler.com/us/stock/biox/cash-flows-from-used-in-operating-activities https://stock.noler.com/us/stock/biox/cash-flows-from-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/biox/cash-flows-from-used-in-operating-activities-ifrs-full https://stock.noler.com/us/stock/biox/clinical-trials https://stock.noler.com/us/stock/biox/closing-foreign-exchange-rate https://stock.noler.com/us/stock/biox/communication-expense https://stock.noler.com/us/stock/biox/company-guidance https://stock.noler.com/us/stock/biox/company-profile https://stock.noler.com/us/stock/biox/comprehensive-income https://stock.noler.com/us/stock/biox/comprehensive-income-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/biox/comprehensive-income-attributable-to-owners-of-parent https://stock.noler.com/us/stock/biox/comprehensive-income-from https://stock.noler.com/us/stock/biox/comprehensive-income-from-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/biox/comprehensive-income-from-attributable-to-owners-of-parent https://stock.noler.com/us/stock/biox/comprehensive-income-from-discontinued-operations https://stock.noler.com/us/stock/biox/comprehensive-income-from-discontinued-operations-attributable-to-owners-of-parent https://stock.noler.com/us/stock/biox/congressional-trades-stocks-including-adrs https://stock.noler.com/us/stock/biox/contingent-liabilities-recognised-in-business-combination https://stock.noler.com/us/stock/biox/convertible-securities-retired https://stock.noler.com/us/stock/biox/cost-of-sales https://stock.noler.com/us/stock/biox/cover-page-shares-outstanding https://stock.noler.com/us/stock/biox/current-advances https://stock.noler.com/us/stock/biox/current-advances-to-suppliers https://stock.noler.com/us/stock/biox/current-agricultural-produce https://stock.noler.com/us/stock/biox/current-assets https://stock.noler.com/us/stock/biox/current-contract-liabilities-for-performance-obligations-satisfied-over-time https://stock.noler.com/us/stock/biox/current-deferred-income-including-current-contract-liabilities https://stock.noler.com/us/stock/biox/current-deposits-from-customers https://stock.noler.com/us/stock/biox/current-finance-lease-liabilities https://stock.noler.com/us/stock/biox/current-government-grants https://stock.noler.com/us/stock/biox/current-inventories-in-transit https://stock.noler.com/us/stock/biox/current-lease-liabilities https://stock.noler.com/us/stock/biox/current-liabilities https://stock.noler.com/us/stock/biox/current-materials-and-supplies-to-be-consumed-in-production-process-or-rendering-services https://stock.noler.com/us/stock/biox/current-payables-on-social-security-and-taxes-other-than-income-tax https://stock.noler.com/us/stock/biox/current-prepaid-expenses https://stock.noler.com/us/stock/biox/current-provisions-for-employee-benefits https://stock.noler.com/us/stock/biox/current-ratio https://stock.noler.com/us/stock/biox/current-tax-assets https://stock.noler.com/us/stock/biox/current-tax-assets-noncurrent https://stock.noler.com/us/stock/biox/current-tax-expense-income https://stock.noler.com/us/stock/biox/current-tax-liabilities https://stock.noler.com/us/stock/biox/current-tax-liabilities-current https://stock.noler.com/us/stock/biox/current-trade-receivables https://stock.noler.com/us/stock/biox/debt-equity-ratio https://stock.noler.com/us/stock/biox/decrease-through-classified-as-held-for-sale-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/biox/decrease-through-classified-as-held-for-sale-property-plant-and-equipment https://stock.noler.com/us/stock/biox/deferred-income-classified-as-current https://stock.noler.com/us/stock/biox/deferred-tax-assets https://stock.noler.com/us/stock/biox/deferred-tax-expense-income https://stock.noler.com/us/stock/biox/deferred-tax-expense-income-recognised-in-profit-or-loss https://stock.noler.com/us/stock/biox/deferred-tax-liabilities https://stock.noler.com/us/stock/biox/deferred-tax-liability-asset https://stock.noler.com/us/stock/biox/deferred-tax-relating-to-items-charged-or-credited-directly-to-equity https://stock.noler.com/us/stock/biox/depreciation-property-plant-and-equipment https://stock.noler.com/us/stock/biox/depreciation-rightofuse-assets https://stock.noler.com/us/stock/biox/description-of-discount-rates-applied-to-cash-flow-projections https://stock.noler.com/us/stock/biox/description-of-expected-volatility-share-options-granted https://stock.noler.com/us/stock/biox/description-of-growth-rate-used-to-extrapolate-cash-flow-projections https://stock.noler.com/us/stock/biox/description-of-option-life-share-options-granted https://stock.noler.com/us/stock/biox/description-of-risk-free-interest-rate-share-options-granted https://stock.noler.com/us/stock/biox/diluted-earnings-loss-per-share https://stock.noler.com/us/stock/biox/diluted-earnings-loss-per-share-from https://stock.noler.com/us/stock/biox/diluted-earnings-loss-per-share-from-discontinued-operations https://stock.noler.com/us/stock/biox/disposals-property-plant-and-equipment https://stock.noler.com/us/stock/biox/dividend https://stock.noler.com/us/stock/biox/dividend-safety https://stock.noler.com/us/stock/biox/dividends-paid https://stock.noler.com/us/stock/biox/dividends-paid-classified-as-financing-activities https://stock.noler.com/us/stock/biox/ebitda https://stock.noler.com/us/stock/biox/ebitda-margin https://stock.noler.com/us/stock/biox/effect-of-exchange-rate-changes-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/biox/employee-count https://stock.noler.com/us/stock/biox/equity https://stock.noler.com/us/stock/biox/equity-and-liabilities https://stock.noler.com/us/stock/biox/equity-attributable-to-owners-of-parent https://stock.noler.com/us/stock/biox/executive-pay-pvp https://stock.noler.com/us/stock/biox/executive-salary-officers https://stock.noler.com/us/stock/biox/exercise-price-share-options-granted-2019 https://stock.noler.com/us/stock/biox/expected-dividend-as-percentage-share-options-granted https://stock.noler.com/us/stock/biox/expense-breakdown https://stock.noler.com/us/stock/biox/expense-from-share-based-payment-transactions-with-employees https://stock.noler.com/us/stock/biox/fee-and-commission-expense https://stock.noler.com/us/stock/biox/finance-costs https://stock.noler.com/us/stock/biox/finance-income https://stock.noler.com/us/stock/biox/finance-income-cost https://stock.noler.com/us/stock/biox/finance-income-received-classified-as-operating-activities https://stock.noler.com/us/stock/biox/financial-liabilities https://stock.noler.com/us/stock/biox/form-144-stocks https://stock.noler.com/us/stock/biox/form-n-port-stocks https://stock.noler.com/us/stock/biox/fuel-and-energy-expense https://stock.noler.com/us/stock/biox/future-finance-charge-on-finance-lease https://stock.noler.com/us/stock/biox/gain-loss-recognised-on-measurement-to-fair-value-less-costs-to-sell-or-on-disposal-of-assets-or-disposal-groups-constituting-discontinued-operation https://stock.noler.com/us/stock/biox/gain-recognised-in-bargain-purchase-transaction https://stock.noler.com/us/stock/biox/gains-losses-on-change-in-fair-value-estimates-of-biological-assets-for-current-period https://stock.noler.com/us/stock/biox/gains-losses-on-exchange-differences-on-translation-net-of-tax https://stock.noler.com/us/stock/biox/gains-losses-on-fair-value-adjustment-attributable-to-price-changes-biological-assets https://stock.noler.com/us/stock/biox/gains-losses-on-fair-value-adjustment-biological-assets https://stock.noler.com/us/stock/biox/gains-losses-recognised-in-profit-or-loss-on-exchange-differences-fair-value-measurement-assets https://stock.noler.com/us/stock/biox/gains-losses-recognised-in-profit-or-loss-on-exchange-differences-fair-value-measurement-liabilities https://stock.noler.com/us/stock/biox/goodwill https://stock.noler.com/us/stock/biox/government-grants https://stock.noler.com/us/stock/biox/graph https://stock.noler.com/us/stock/biox/gross-margin https://stock.noler.com/us/stock/biox/gross-profit https://stock.noler.com/us/stock/biox/impairment-loss-recognised-in-profit-or-loss-trade-receivables https://stock.noler.com/us/stock/biox/included-in-etf https://stock.noler.com/us/stock/biox/income-from-attributable-to-owners-of-parent https://stock.noler.com/us/stock/biox/income-from-discontinued-operations-attributable-to-owners-of-parent https://stock.noler.com/us/stock/biox/income-tax-expense https://stock.noler.com/us/stock/biox/income-tax-relating-to-changes-in-revaluation-surplus-of-other-comprehensive-income https://stock.noler.com/us/stock/biox/income-tax-relating-to-components-of-other-comprehensive-income https://stock.noler.com/us/stock/biox/increase-decrease-in-cash-and-cash-equivalents-before-effect-of-exchange-rate-changes https://stock.noler.com/us/stock/biox/increase-decrease-in-cash-and-cash-equivalents-discontinued-operations https://stock.noler.com/us/stock/biox/increase-decrease-in-fair-value-measurement-due-to-reasonably-possible-increase-in-unobservable-input-assets https://stock.noler.com/us/stock/biox/increase-decrease-in-financial-assets https://stock.noler.com/us/stock/biox/increase-decrease-through-acquisition-of-subsidiary https://stock.noler.com/us/stock/biox/increase-decrease-through-business-combinations-deferred-tax-liability-asset https://stock.noler.com/us/stock/biox/increase-decrease-through-changes-in-ownership-interests-in-subsidiaries-that-do-not-result-in-loss-of-control https://stock.noler.com/us/stock/biox/increase-decrease-through-effect-of-changes-in-foreign-exchange-rates-liabilities-arising-from-financing-activities https://stock.noler.com/us/stock/biox/increase-decrease-through-exercise-of-options https://stock.noler.com/us/stock/biox/increase-decrease-through-exercise-of-warrants-equity https://stock.noler.com/us/stock/biox/increase-decrease-through-net-exchange-differences-biological-assets https://stock.noler.com/us/stock/biox/increase-decrease-through-net-exchange-differences-deferred-tax-liability-asset https://stock.noler.com/us/stock/biox/increase-decrease-through-net-exchange-differences-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/biox/increase-decrease-through-net-exchange-differences-other-provisions https://stock.noler.com/us/stock/biox/increase-decrease-through-net-exchange-differences-property-plant-and-equipment https://stock.noler.com/us/stock/biox/increase-decrease-through-share-based-payment-transactions https://stock.noler.com/us/stock/biox/increase-decrease-through-transfers-from-to-investment-property-property-plant-and-equipment https://stock.noler.com/us/stock/biox/increase-decrease-through-transfers-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/biox/increase-decrease-through-transfers-property-plant-and-equipment https://stock.noler.com/us/stock/biox/increase-decrease-through-treasury-share-transactions https://stock.noler.com/us/stock/biox/insider-transactions https://stock.noler.com/us/stock/biox/insurance-expense https://stock.noler.com/us/stock/biox/intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/biox/intangible-assets-with-indefinite-useful-life https://stock.noler.com/us/stock/biox/interest-costs-capitalised https://stock.noler.com/us/stock/biox/interest-expense-on-other-financial-liabilities https://stock.noler.com/us/stock/biox/interest-income-on-other-financial-assets https://stock.noler.com/us/stock/biox/interest-paid-classified-as-financing-activities https://stock.noler.com/us/stock/biox/inventories https://stock.noler.com/us/stock/biox/inventories-total https://stock.noler.com/us/stock/biox/investment-accounted-for-using-equity-method https://stock.noler.com/us/stock/biox/investment-property https://stock.noler.com/us/stock/biox/investments-in-subsidiaries-joint-ventures-and-associates https://stock.noler.com/us/stock/biox/investments-other-than-investments-accounted-for-using-equity-method https://stock.noler.com/us/stock/biox/iran-activity-notices-irannotice https://stock.noler.com/us/stock/biox/issue-of-convertible-instruments https://stock.noler.com/us/stock/biox/issue-of-equity https://stock.noler.com/us/stock/biox/key-management-personnel-compensation https://stock.noler.com/us/stock/biox/key-management-personnel-compensation-share-based-payment https://stock.noler.com/us/stock/biox/key-management-personnel-compensation-shortterm-employee-benefits https://stock.noler.com/us/stock/biox/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/biox/lease-liabilities https://stock.noler.com/us/stock/biox/liabilities-arising-from-financing-activities https://stock.noler.com/us/stock/biox/liabilities-included-in-disposal-groups-classified-as-held-for-sale https://stock.noler.com/us/stock/biox/liabilities-incurred https://stock.noler.com/us/stock/biox/licence-fee-income https://stock.noler.com/us/stock/biox/longterm-borrowings https://stock.noler.com/us/stock/biox/market-cap https://stock.noler.com/us/stock/biox/material-contracts https://stock.noler.com/us/stock/biox/minimum-finance-lease-payments-payable https://stock.noler.com/us/stock/biox/minimum-finance-lease-payments-payable-at-present-value https://stock.noler.com/us/stock/biox/minimum-lease-payments-payable-under-noncancellable-operating-lease https://stock.noler.com/us/stock/biox/miscellaneous-other-operating-expense https://stock.noler.com/us/stock/biox/net-deferred-tax-assets https://stock.noler.com/us/stock/biox/net-deferred-tax-liabilities https://stock.noler.com/us/stock/biox/net-margin https://stock.noler.com/us/stock/biox/news https://stock.noler.com/us/stock/biox/noncontrolling-interests https://stock.noler.com/us/stock/biox/noncurrent-advances https://stock.noler.com/us/stock/biox/noncurrent-assets https://stock.noler.com/us/stock/biox/noncurrent-assets-or-disposal-groups-classified-as-held-for-sale-or-as-held-for-distribution-to-owners https://stock.noler.com/us/stock/biox/noncurrent-assets-other-than-financial-instruments-deferred-tax-assets-postemployment-benefit-assets-and-rights-arising-under-insurance-contracts https://stock.noler.com/us/stock/biox/noncurrent-contract-liabilities https://stock.noler.com/us/stock/biox/noncurrent-contract-liabilities-for-performance-obligations-satisfied-over-time https://stock.noler.com/us/stock/biox/noncurrent-deferred-income-including-noncurrent-contract-liabilities https://stock.noler.com/us/stock/biox/noncurrent-finance-lease-liabilities https://stock.noler.com/us/stock/biox/noncurrent-financial-assets-available-for-sale https://stock.noler.com/us/stock/biox/noncurrent-government-grants https://stock.noler.com/us/stock/biox/noncurrent-lease-liabilities https://stock.noler.com/us/stock/biox/noncurrent-liabilities https://stock.noler.com/us/stock/biox/noncurrent-payables https://stock.noler.com/us/stock/biox/noncurrent-payables-to-related-parties https://stock.noler.com/us/stock/biox/noncurrent-payables-to-trade-suppliers https://stock.noler.com/us/stock/biox/noncurrent-portion-of-noncurrent-bonds-issued https://stock.noler.com/us/stock/biox/noncurrent-provisions https://stock.noler.com/us/stock/biox/noncurrent-provisions-for-employee-benefits https://stock.noler.com/us/stock/biox/noncurrent-receivables https://stock.noler.com/us/stock/biox/noncurrent-trade-receivables https://stock.noler.com/us/stock/biox/number-of-instruments-or-interests-issued-or-issuable https://stock.noler.com/us/stock/biox/number-of-outstanding-share-options https://stock.noler.com/us/stock/biox/number-of-share-options-granted-in-share-based-payment-arrangement https://stock.noler.com/us/stock/biox/oci-net-of-tax-exchange-differences-on-translation-other-than-translation-of-foreign-operations https://stock.noler.com/us/stock/biox/oci-net-of-tax-gains-losses-on-revaluation https://stock.noler.com/us/stock/biox/oci-that-will-be-reclassified-to-profit-or-loss-net-of-tax https://stock.noler.com/us/stock/biox/oci-that-will-not-be-reclassified-to-profit-or-loss-net-of-tax https://stock.noler.com/us/stock/biox/operating-margin https://stock.noler.com/us/stock/biox/options-activity https://stock.noler.com/us/stock/biox/other-cash-payments-to-acquire-interests-in-joint-ventures-classified-as-investing-activities https://stock.noler.com/us/stock/biox/other-comprehensive-income https://stock.noler.com/us/stock/biox/other-current-assets https://stock.noler.com/us/stock/biox/other-current-financial-assets https://stock.noler.com/us/stock/biox/other-current-payables https://stock.noler.com/us/stock/biox/other-current-receivables https://stock.noler.com/us/stock/biox/other-finance-income-cost https://stock.noler.com/us/stock/biox/other-inflows-outflows-of-cash-classified-as-financing-activities https://stock.noler.com/us/stock/biox/other-longterm-provisions https://stock.noler.com/us/stock/biox/other-noncurrent-financial-assets https://stock.noler.com/us/stock/biox/other-noncurrent-receivables https://stock.noler.com/us/stock/biox/other-operating-income-expense https://stock.noler.com/us/stock/biox/other-provisions https://stock.noler.com/us/stock/biox/other-receivables https://stock.noler.com/us/stock/biox/other-tax-effects-for-reconciliation-between-accounting-profit-and-tax-expense-income https://stock.noler.com/us/stock/biox/outstanding-bonds https://stock.noler.com/us/stock/biox/par-value-per-share https://stock.noler.com/us/stock/biox/patents-active https://stock.noler.com/us/stock/biox/payments-for-development-project-expenditure https://stock.noler.com/us/stock/biox/payments-from-changes-in-ownership-interests-in-subsidiaries https://stock.noler.com/us/stock/biox/payments-of-lease-liabilities-classified-as-financing-activities https://stock.noler.com/us/stock/biox/payments-to-acquire-or-redeem-entitys-shares https://stock.noler.com/us/stock/biox/pb-ratio https://stock.noler.com/us/stock/biox/pe-ratio https://stock.noler.com/us/stock/biox/percentage-of-reasonably-possible-increase-in-unobservable-input-assets https://stock.noler.com/us/stock/biox/pre-tax-margin https://stock.noler.com/us/stock/biox/preferred-shares https://stock.noler.com/us/stock/biox/previous-etf-holding-it https://stock.noler.com/us/stock/biox/price-fcf-ratio https://stock.noler.com/us/stock/biox/proceeds-from-borrowings-classified-as-financing-activities https://stock.noler.com/us/stock/biox/proceeds-from-disposal-or-maturity-of-available-for-sale-financial-assets https://stock.noler.com/us/stock/biox/proceeds-from-issue-of-preference-shares https://stock.noler.com/us/stock/biox/proceeds-from-sale-or-issue-of-treasury-shares https://stock.noler.com/us/stock/biox/proceeds-from-sales-of-investments-accounted-for-using-equity-method https://stock.noler.com/us/stock/biox/proceeds-from-sales-of-property-plant-and-equipment-classified-as-investing-activities https://stock.noler.com/us/stock/biox/professional-fees-expense https://stock.noler.com/us/stock/biox/profit-breakdown https://stock.noler.com/us/stock/biox/profit-loss https://stock.noler.com/us/stock/biox/profit-loss-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/biox/profit-loss-attributable-to-ordinary-equity-holders-of-parent-entity https://stock.noler.com/us/stock/biox/profit-loss-attributable-to-ordinary-equity-holders-of-parent-entity-including-dilutive-effects https://stock.noler.com/us/stock/biox/profit-loss-attributable-to-owners-of-parent https://stock.noler.com/us/stock/biox/profit-loss-before-tax https://stock.noler.com/us/stock/biox/profit-loss-from https://stock.noler.com/us/stock/biox/profit-loss-from-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/biox/profit-loss-from-attributable-to-ordinary-equity-holders-of-parent-entity https://stock.noler.com/us/stock/biox/profit-loss-from-attributable-to-ordinary-equity-holders-of-parent-entity-including-dilutive-effects https://stock.noler.com/us/stock/biox/profit-loss-from-discontinued-operations https://stock.noler.com/us/stock/biox/profit-loss-from-discontinued-operations-attributable-to-ordinary-equity-holders-of-parent-entity https://stock.noler.com/us/stock/biox/profit-loss-from-discontinued-operations-attributable-to-ordinary-equity-holders-of-parent-entity-including-dilutive-effects https://stock.noler.com/us/stock/biox/profit-loss-from-operating-activities https://stock.noler.com/us/stock/biox/property-plant-and-equipment https://stock.noler.com/us/stock/biox/property-plant-and-equipment-carrying-amount-at-cost-of-revalued-assets https://stock.noler.com/us/stock/biox/ps-ratio https://stock.noler.com/us/stock/biox/purchase-of-available-for-sale-financial-assets https://stock.noler.com/us/stock/biox/purchase-of-intangible-assets-classified-as-investing-activities https://stock.noler.com/us/stock/biox/purchase-of-investment-property https://stock.noler.com/us/stock/biox/purchase-of-property-plant-and-equipment-classified-as-investing-activities https://stock.noler.com/us/stock/biox/quick-ratio https://stock.noler.com/us/stock/biox/repairs-and-maintenance-expense https://stock.noler.com/us/stock/biox/repayments-of-borrowings-classified-as-financing-activities https://stock.noler.com/us/stock/biox/research-and-development https://stock.noler.com/us/stock/biox/return-on-tangible-equity https://stock.noler.com/us/stock/biox/revaluation-increase-decrease-property-plant-and-equipment https://stock.noler.com/us/stock/biox/revenue https://stock.noler.com/us/stock/biox/revenue-breakdown https://stock.noler.com/us/stock/biox/revenue-from-contracts-with-customers https://stock.noler.com/us/stock/biox/revenue-from-government-grants https://stock.noler.com/us/stock/biox/revenue-from-royalties https://stock.noler.com/us/stock/biox/revenue-from-sale-of-agricultural-produce https://stock.noler.com/us/stock/biox/rightofuse-assets https://stock.noler.com/us/stock/biox/risk-exposure-associated-with-instruments-sharing-characteristic https://stock.noler.com/us/stock/biox/roa https://stock.noler.com/us/stock/biox/roe https://stock.noler.com/us/stock/biox/roi https://stock.noler.com/us/stock/biox/scorecard https://stock.noler.com/us/stock/biox/sec-comment-letters-upload https://stock.noler.com/us/stock/biox/sec-enforcement-actions https://stock.noler.com/us/stock/biox/sec-filings-10-q https://stock.noler.com/us/stock/biox/sec-filings-25-nse https://stock.noler.com/us/stock/biox/sec-filings-8-k https://stock.noler.com/us/stock/biox/sec-filings-px14a6g https://stock.noler.com/us/stock/biox/sec-filings-s-4 https://stock.noler.com/us/stock/biox/secondary-offerings https://stock.noler.com/us/stock/biox/sga-expense https://stock.noler.com/us/stock/biox/share-of-profit-loss-of-associates-and-joint-ventures-accounted-for-using-equity-method https://stock.noler.com/us/stock/biox/share-of-total-comprehensive-income-of-associates-and-joint-ventures-accounted-for-using-equity-method https://stock.noler.com/us/stock/biox/shares-in-entity-held-by-entity-or-by-its-subsidiaries-or-associates https://stock.noler.com/us/stock/biox/shares-outstanding https://stock.noler.com/us/stock/biox/short-sale-volume https://stock.noler.com/us/stock/biox/shortterm-borrowings https://stock.noler.com/us/stock/biox/shortterm-deposits-not-classified-as-cash-equivalents https://stock.noler.com/us/stock/biox/shortterm-employee-benefits-expense https://stock.noler.com/us/stock/biox/shortterm-investments-classified-as-cash-equivalents https://stock.noler.com/us/stock/biox/stock-issued https://stock.noler.com/us/stock/biox/stock-splits https://stock.noler.com/us/stock/biox/subsidiaries https://stock.noler.com/us/stock/biox/tax-effect-from-change-in-tax-rate https://stock.noler.com/us/stock/biox/tax-effect-of-revenues-exempt-from-taxation-2011 https://stock.noler.com/us/stock/biox/tax-effect-of-tax-losses https://stock.noler.com/us/stock/biox/tax-expense-income-at-applicable-tax-rate https://stock.noler.com/us/stock/biox/temporary-differences-associated-with-investments-in-subsidiaries-branches-and-associates-and-interests-in-joint-ventures https://stock.noler.com/us/stock/biox/total-assets https://stock.noler.com/us/stock/biox/total-liabilities https://stock.noler.com/us/stock/biox/trade-and-other-current-payables https://stock.noler.com/us/stock/biox/trade-and-other-current-payables-to-trade-suppliers https://stock.noler.com/us/stock/biox/trade-and-other-current-receivables https://stock.noler.com/us/stock/biox/travel-expense https://stock.noler.com/us/stock/biox/unused-tax-credits-for-which-no-deferred-tax-asset-recognised https://stock.noler.com/us/stock/biox/unused-tax-losses-for-which-no-deferred-tax-asset-recognised https://stock.noler.com/us/stock/biox/weighted-average-fair-value-at-measurement-date-share-options-granted https://stock.noler.com/us/stock/biox/weighted-average-lessees-incremental-borrowing-rate-applied-to-lease-liabilities-recognised-at-date-of-initial-application-of-ifrs-16 https://stock.noler.com/us/stock/biox/weighted-average-share-price-share-options-granted-2019 https://stock.noler.com/us/stock/biox/weighted-average-shares